STOCK TITAN
  1. Home
  2. VHAQ

Viveon Health Acquisition Stock Price, News & Analysis

VHAQ OTC

Company Description

Viveon Health Acquisition (OTC: VHAQ) is a publicly traded company.

VHAQ stock has declined 11.6% over the past year.

This page provides a comprehensive overview of VHAQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-11.58%
Performance 1 year
$0.0
Market Cap
5.7M
Shares outstanding

Viveon Health Acquisition (VHAQ) stock. Over the past 12 months, the stock has lost 11.6%.

Latest News

View All
+0.94%

Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement

acquisition
+0.39%

Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP Treatments

0.00%

Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Suneva Medical

acquisition
0.00%

Suneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and Canada

0.00%

Viveon Health Acquisition Corp. Received Audit Opinion with Going Concern Explanation

acquisition
0.00%

Viveon Health Acquisition Corp. Announces Board and Stockholder Approval to Extend Period to Consummate Business Combination

acquisition

Viveon Health Acquisition has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, clinical trial, fda approval. View all VHAQ news →

SEC Filings

View All

No SEC filings available for VHAQ.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months